Cited by 74Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Neuroinflammation in Alzheimer’s disease: Pleiotropic roles for cytokines and neuronal pentraxins

Open access
Swanson, Ashley, Wolf, Tovah, Sitzmann, Alli, Willette, Auriel A.·2018·Behavioural Brain Research

Abstract

Neuroinflammation is a potential factor speculated to underlie Alzheimer's disease (AD) etiopathogenesis and progression. The overwhelming focus in this area of research to date has been on the chronic upregulation of pro-inflammatory cytokines to understand how neuroinflammatory mechanisms contribute to neurodegeneration. Yet, it is important to understand the pleiotropic roles of these cytokines in modulating neuroinflammation in which they cannot be labeled as a strictly "good" or "bad" biomarker phenotype. As such, biomarkers with more precise functions are needed to better understand how neuroinflammation impacts the brain in AD. Neuronal pentraxins are a concentration- dependent group of pro- or anti- inflammatory cytokines. There is contradictory evidence of these pentraxins as being both neuroprotective and potentially detrimental in AD. Potential neuroprotective examples include their ability to predict AD-related outcomes such as cognition, memory function and synaptic refinement. This review will briefly outline the basis of AD and subsequently summarize findings for neuropathological mechanisms of neuroinflammation, roles for traditional pro-and anti-inflammatory cytokines, and data found thus far on the neuronal pentraxins.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbr.2018.02.015

Cites

182 of 183 references verified1 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [58]Krstic D Knuesel I Deciphering the mechanism underlying late-onset Alzheimer disease Nat Rev Neurol 9 2012 25 34 10.1038/nrneurol.2012.236 23183882 · DOI · Paper page
  2. [177]Xiao M-F Xu D Craig MT Pelkey KA Chien C-C Shi Y Zhang J Resnick S Pletnikova O Salmon D Brewer J Edland S Wegiel J Tycko B Savonenko A Reeves RH Troncoso JC McBain CJ Galasko D Worley PF NPTX2 and cognitive dysfunction in Alzheimer’s Disease Elife 6 2017 10.7554/eLife.23798 PMC5404919 28440221 · DOI · Paper page

Cited by

Sorted by citations

Authors
Swanson, A., Wolf, T., Sitzmann, A., & Willette, A. A.
Affiliations
  • Iowa State University (US)
  • University of Iowa (US)
Corresponding author
Willette, Auriel A.
Venue
Behavioural Brain Research
Publisher
Elsevier BV
Published
2018-07
Volume
347
Pages
49-56
ISSN
0166-4328 (ISSN-L)
OpenAlex
W2789287723
Cited by
72
References
182
Citations by year
2026: 5 · 2025: 7 · 2024: 18 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 7
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • Behavioural Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • College of Human Sciences at Iowa State University, a Big Data Brain Initiative grant through the Iowa State University Office of Vice President for Research (AG047282)
  • Alzheimer's Association Research Grant to Promote Diversity (AARGD-17-529552)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
neuroinflammation, Alzheimer's disease, cytokines, inflammatory cytokines, anti-inflammatory cytokines, neuroprotection, neurodegeneration, biomarkers, cognition, memory, synaptic refinement
MeSH terms
Pentraxins, Alzheimer Disease, Animals, C-Reactive Protein, Humans, Inflammation, Nerve Tissue Proteins, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review